We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6436:TSEAmano Corporation Analysis

Data as of 2026-05-27 - not real-time

¥3,553.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Amano Corp (6436.T) is trading at ¥3,553, well below its 20‑day (¥3,643) and 50‑day (¥3,778) simple moving averages, indicating short‑term weakness. The RSI of 34 suggests the stock is approaching oversold territory, while a bearish MACD histogram reinforces a near‑term bearish bias. However, the valuation metrics paint a contrasting picture: a trailing PE of 12.4 versus an industry average of 40.6, a price‑to‑book of 1.78, and a dividend yield of 7.0% signal substantial value and income appeal. The DCF‑derived fair value of roughly ¥2,897 suggests the market may be pricing in a premium, yet the low beta of 0.22 and strong cash position (¥61.7 bn) mitigate downside concerns.
Recent corporate actions add a catalyst: the board’s revised capital policy lifts payout targets and introduces flexible share repurchases, aligning with a 30‑day price gain of 7.2% and a YTD return of 14.7%. Coupled with a stable operating margin of 15% and solid free cash flow, these fundamentals support a medium‑to‑long‑term case for accumulation, despite the current bearish technical backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMA, MACD, RSI)
  • High dividend yield providing downside cushion
  • Recent capital policy enhancing shareholder returns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (PE 12.4 vs industry 40.6)
  • Sustainable dividend payout supported by strong cash balance
  • Low volatility and beta indicating defensive profile

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable earnings and cash generation from diversified product lines
  • Ongoing shareholder-friendly capital allocation (share repurchases, dividend hikes)
  • Low systemic risk due to low beta and solid balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth-0.20%
Profit Margin11.42%
P/E Ratio12.4
ROE14.68%
ROA7.28%
Debt/Equity10.54
P/B Ratio1.8
Op. Cash Flow¥24.9B
Free Cash Flow¥11.8B
Industry P/E40.6

Technical Analysis

TrendBearish
RSI34.2
Support¥3,524.00
Resistance¥3,929.00
MA 20¥3,643.35
MA 50¥3,778.26
MA 200¥4,061.21
MACDBearish
VolumeDecreasing
Fear & Greed Index91.34

Valuation

Fair Value¥2,896.84
Target Price¥4,725.00
Upside/Downside32.99%
GradeUndervalued
TypeValue
Dividend Yield7.04%

Risk Assessment

Beta0.22
Volatility21.12%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.